Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Segal

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Radiation Research|September 7, 2017
Radiation Mitigating Properties of Intranasally Administered KL<sub>4</sub> Surfactant in a Murine Model of Radiation-Induced Lung DamageMelpo Christofidou-Solomidou, Ralph A Pietrofesa, Evguenia Arguiri, et al.
BJU International|September 3, 2011
Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?Robert Segal, Faysal A Yafi, Fadi Brimo, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 7, 2020
Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasiaCraig A Gelfand, Reiko Sakurai, Ying Wang, et al.
Inhalation Toxicology|December 17, 2015
Characterization of a nose-only inhaled phosgene acute lung injury mouse modelJennifer L Plahovinsak, Mark R Perry, Katherine A Knostman, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 12, 2010
An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonatesNeil N Finer, T Allen Merritt, Graham Bernstein, et al.
The Journal of Infectious Diseases|February 25, 2003
Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapyKrishanthi S Subramaniam, Robert Segal, Robert H Lyles, et al.
Dermatology Online Journal|September 8, 2020
Allergenic potential, marketing claims, and pricing of facial moisturizersAlyssa M Thompson, Bryan Kromenacker, Tiffany Y Loh, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|December 22, 2012
A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfaCarlos G Guardia, Fernando R Moya, Sunil Sinha, et al.
Pediatrics|May 30, 2007
One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trialsFernando Moya, Sunil Sinha, Janusz Gadzinowski, et al.
Pediatric Pulmonology|July 28, 2006
KL4-surfactant prevents hyperoxic and LPS-induced lung injury in micePaul Kinniry, Jeremy Pick, Scott Stephens, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Radiation Research|September 7, 2017
Radiation Mitigating Properties of Intranasally Administered KL<sub>4</sub> Surfactant in a Murine Model of Radiation-Induced Lung DamageMelpo Christofidou-Solomidou, Ralph A Pietrofesa, Evguenia Arguiri, et al.
BJU International|September 3, 2011
Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?Robert Segal, Faysal A Yafi, Fadi Brimo, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 7, 2020
Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasiaCraig A Gelfand, Reiko Sakurai, Ying Wang, et al.
Inhalation Toxicology|December 17, 2015
Characterization of a nose-only inhaled phosgene acute lung injury mouse modelJennifer L Plahovinsak, Mark R Perry, Katherine A Knostman, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 12, 2010
An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonatesNeil N Finer, T Allen Merritt, Graham Bernstein, et al.
The Journal of Infectious Diseases|February 25, 2003
Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapyKrishanthi S Subramaniam, Robert Segal, Robert H Lyles, et al.
Dermatology Online Journal|September 8, 2020
Allergenic potential, marketing claims, and pricing of facial moisturizersAlyssa M Thompson, Bryan Kromenacker, Tiffany Y Loh, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|December 22, 2012
A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfaCarlos G Guardia, Fernando R Moya, Sunil Sinha, et al.
Pediatrics|May 30, 2007
One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trialsFernando Moya, Sunil Sinha, Janusz Gadzinowski, et al.
Pediatric Pulmonology|July 28, 2006
KL4-surfactant prevents hyperoxic and LPS-induced lung injury in micePaul Kinniry, Jeremy Pick, Scott Stephens, et al.
Pageof 4